LSBio
TNFRSF10A / DR4 Antibody (Extracellular Domain, clone DJR1)

Human DR4 transfected cells stained with purified DJR1, followed by anti-mouse IgG FITC

TNFRSF10A / DR4 Antibody (Extracellular Domain, clone DJR1)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Flow Cytometry, Immunohistochemistry (general)
Reactivity:Human
Format:Liquid
See all Human TNFRSF10A / DR4 antibodies →
$282.00each
Catalog Number: LS-C40989-25

For bulk orders or custom formulations:

Request a Quote

Overview

Description
DR4 antibody LS-C40989 is an unconjugated mouse monoclonal antibody to human DR4 (TNFRSF10A) (Extracellular Domain). Validated for Flow. Cited in 2 publications.
Application
FC, IHC
Reactivity
Hu
Intended Use
RUO
Guarantees
This antibody carries the LSBio 100% Guarantee. ✓
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
APO2 | CD261 | DR4 | TNFRSF10A | TRAIL-R1 | TRAILR-1 | TRAILR1 | TRAIL receptor 1 | CD261 antigen | Cytotoxic TRAIL receptor | Death receptor 4
NCBI GenBank
NM_003844

Target

Target
Human TNFRSF10A / DR4
Antigen Species
Hu
Epitope
Extracellular domain of DR4-human IgG1 Fc fusion protein

Antibody

Host Species
Ms
Clonality
Monoclonal
Clone
DJR1
Isotype
IgG1

Immunogen

Immunogen
Recombinant human TNFRSF10A / DR4.
Immunogen Type
Recom

Format

Conjugate/Label
Unconj
Format
Liquid
Formulation
Phosphate-buffered solution, pH 7.2, 0.09% sodium azide.
Concentration
0.5 mg/mL
Preservative
Yes
Purification Method
AP

Storage & Handling

Storage Conditions
Store at 4°C.
Recommended Storage Buffer
Phosphate-buffered
Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Lundqvist A, Abrams SI, Schrump DS, Alvarez G, Suffredini D, Berg M, Childs R. Cancer research. 2006;66:7317-25. PubMed: 16849582

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.